Tibet Cheezheng Tibetan Medicine Co., Ltd. (SZSE: 002287)
Health Care · Pharmaceuticals · CN
CN¥19.38
+0.05% today · -25.6% 1Y
Tibet Cheezheng Tibetan Medicine Co., Ltd. (SZSE: 002287) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.64B and employs 3,203 people.
Over the last twelve months the share price has lost 25.6%, trading between 18.33 and 27.33.
Tweenvest scores Tibet Cheezheng Tibetan Medicine Co., Ltd. across four factors: quality 85/100, value 73/100, growth 65/100, dividend 45/100. Its strongest factor is quality.
002287 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.64B
- Revenue (TTM)
- $326.66M
- P/E
- 16.45
- EPS
- 1.18
- Dividend yield
- 3.30%
- Beta (5Y)
- 0.20
- 52-week high
- CN¥27.33
- 52-week low
- CN¥18.33
- Avg volume (3M)
- —
- Shares outstanding
- 566.88M
- Employees
- 3,203
- Next earnings
- —
About Tibet Cheezheng Tibetan Medicine Co., Ltd.
Tibet Cheezheng Tibetan Medicine Co., Ltd., along with its affiliated entities, specializes in the entire lifecycle of traditional Tibetan pharmaceuticals, from their research and development to manufacturing and distribution across China. The company's diverse range of drug products addresses various medical conditions, including those impacting the cardiovascular, respiratory, digestive, nervous, and musculoskeletal systems, as well as urinary, reproductive, and gynecological health. Established in 1995, the firm is headquartered in Nyingchi, China, and operates as a subsidiary of Gansu Qizheng Industry Group Co., Ltd.
- ISIN
- CNE100000FM9
- Founded
- 1995
- Listed since
- Aug 28, 2009
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alembic Pharmaceuticals LimitedNSEI: APLLTD | $1.66B | Rs815.25 | -5.62% |
| Shenzhen Chipscreen Biosciences Co., Ltd.SHSE: 688321 | $1.66B | CN¥25.22 | -0.51% |
| Faes Farma, S.A.BME: FAE | $1.65B | €4.74 | -0.11% |
| Jubilant Pharmova LimitedBSE: 530019 | $1.65B | Rs1,000.65 | -6.84% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd.SHSE: 600572 | $1.63B | CN¥4.31 | +2.38% |
| Henan Lingrui Pharmaceutical Co., Ltd.SHSE: 600285 | $1.60B | CN¥18.98 | +1.55% |
| Ocular Therapeutix, Inc.NasdaqGM: OCUL | $1.59B | $7.23 | -1.50% |
| Consun Pharmaceutical Group LimitedSEHK: 1681 | $1.59B | HK$14.85 | -0.54% |
Figures last refreshed Oct 4, 2026.